Literature DB >> 17854756

Anterior ischemic optic neuropathy in patients younger than 50 years.

Pisit Preechawat1, Beau B Bruce, Nancy J Newman, Valérie Biousse.   

Abstract

PURPOSE: To characterize anterior ischemic optic neuropathy (AION) in patients younger than 50 years.
DESIGN: Retrospective study.
METHODS: Records of all AION patients seen between 1989 and 2006 were reviewed. Patients younger than 50 years when initial visual loss occurred were included.
RESULTS: Of 727 consecutive patients with AION, 169 (23%) were younger than 50 years (median, 43 years; range, 13 to 49 years; 58% men; 93% White). Involvement was unilateral in 59% of patients and bilateral in 41%. At least one cardiovascular risk factor was found in 74% of patients. Hypercoagulable states and vasculitis were found in 8%. An underlying small or anomalous optic disk was found in 92% of eyes (210/230). Isolated disk anomalies (without systemic risk factors) were present in 26% of eyes. Final visual acuities were 20/40 or better in 64% of eyes and 20/200 or worse in 22%. Among patients with bilateral involvement, final visual acuity was similar in the two eyes in 70% of patients. Anemia and type I diabetes were associated significantly with fellow eye involvement. Recurrent AION in the same eye occurred in 6% of patients.
CONCLUSIONS: AION in younger patients is not uncommon and represents 23% of AION patients in a tertiary neuro-ophthalmic service. Except for giant cell arteritis, ocular and systemic risk factors and associated disorders are similar to those described in older AION patients. Younger AION patients have better visual acuity outcomes but a higher risk of fellow eye involvement than older AION patients.

Entities:  

Mesh:

Year:  2007        PMID: 17854756     DOI: 10.1016/j.ajo.2007.07.031

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  23 in total

1.  Non-arteritic anterior ischemic optic neuropathy and thrombophilia.

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-10-29       Impact factor: 3.117

2.  SSRI-associated optic neuropathy.

Authors:  J Lochhead
Journal:  Eye (Lond)       Date:  2015-07-03       Impact factor: 3.775

3.  Changes in Visual Function over Time in Koreans with Non-arteritic Anterior Ischaemic Optic Neuropathy.

Authors:  Ji Woong Chang; Jin Choi; Young Suk Yu; Seong-Joon Kim
Journal:  Neuroophthalmology       Date:  2014-02-07

4.  Glutathione-S-Transferase Deletions and Non-arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Wencui Wan; Tao Peng; Xuemin Jin; Qiuming Li; Fengyan Zhang; Guangying Zheng; Yong Lv; Guangming Wan; Yu Zhu
Journal:  Mol Neurobiol       Date:  2015-05-20       Impact factor: 5.590

5.  Diffusion tensor imaging of the optic nerve in subacute anterior ischemic optic neuropathy at 3T.

Authors:  M-Y Wang; P-H Qi; D-P Shi
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

6.  Non-arteritic anterior ischaemic optic neuropathy in Malaysia: a 5 years review.

Authors:  Abdulrahman Bawazir; Reza Gharebaghi; Adil Hussein; Wan Hazabbah Wan Hitam
Journal:  Int J Ophthalmol       Date:  2011-06-18       Impact factor: 1.779

7.  Very Poor Visual Acuity in Non-Arteritic Anterior Ischaemic Optic Neuropathy.

Authors:  Michael Dattilo; Tian Tian; Jason H Peragallo; Nancy J Newman; Valérie Biousse
Journal:  Neuroophthalmology       Date:  2020-07-22

Review 8.  Treatment of nonarteritic anterior ischemic optic neuropathy.

Authors:  Edward J Atkins; Beau B Bruce; Nancy J Newman; Valérie Biousse
Journal:  Surv Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 6.048

9.  A new characterization for nonarteritic anterior ischemic optic neuropathy.

Authors:  Aipeng Li; Lin Li; Miyang Li; Xiaoru Shi
Journal:  Int J Clin Exp Med       Date:  2015-10-15

10.  The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis).

Authors:  Anthony C Arnold; Roberta M S Costa; Oana M Dumitrascu
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.